« A disruptive technology, which can be applied in the treatment of numerous conditions »

THERANEXUS publishes its cash position as of 31 December 2022 and announces organizational changes

18/01/2023 before market opens

Download PDF File (<1Mo)

New advance to the Theranexus and BBDF Batten-1 program for juvenile Batten disease (CLN3)


Download PDF File (<1Mo)